This Is MS - MS Walking Improvement Drug Gets FDA Help | Unbiased Multiple Sclerosis Research, News, and Support Community

Modules

· Home
· Content
· Downloads
· Encyclopedia
· FAQ
· Feedback
· Forums
· Journal
· Private Messages
· Recommend Us
· Search
· Site_Map
· Stories Archive
· Submit News
· Surveys
· Top 10
· Topics
· Web Links
· Your Account

Google

These ads help pay for the upkeep of our site. They are automatically served by Google and are not affiliated with This is MS.

Languages

Select Interface Language:

Who's Online

There are currently, 59 guest(s) and 10 member(s) that are online.

You are Anonymous user. You can register for free by clicking here

Next Step

From the creators of This is MS comes Experience Project

EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at Experience Project.

Get started by sharing your Multiple Sclerosis story.

Donations

To remain unbiased, This is MS does not accept corporate sponsorships.

Therefore, we must rely on our users to help support us. Please donate to our upkeep if you have the means. Thank you!

MS Walking Improvement Drug Gets FDA Help

Fampridine-SR

Most of the MS therapies in the drug development pipeline, or even available today, are targeted at reducing relapses and decreasing disability progression.

Which makes Acorda Therapeutics' Fampridine-SR quite interesting. In Phase III trials, it is targeted specifically at one particularly onerous aspect of the MS burden-- impact on walking ability.

Acorda and the United States Food and Drug Administration recently reached an agreement on a pathway to getting Fampridine approved for this indication. In addition to a Phase III trial currently underway, Acorda will work with the FDA's Special Protocol Assessment (SPA) to ensure their trial design proves that individuals treated with Fampridine-SR are significantly more likely to have consistent improvements in their walking than those treated with placebo...

Story continues, please click 'read more'

Advertisement

The rest of this story is hosted at our sister site, Experience Project.com*

MS Walking Improvement Drug Gets FDA Help

*Experience Project is where you can meet people who understand you. Check it out-- we're really proud of it and would love your visit!

Login

Don't have an account yet? You can create one. As a registered user you have some advantages like theme manager, comments configuration and post comments with your name.

Related Links

· More about Fampridine-SR
· News by Administrator

Most read story about Fampridine-SR:
MS Walking Improvement Drug Gets FDA Help

Article Rating

Average Score: 5
Votes: 4

Options

Printer Friendly

Printer Friendly

We encourage you to also visit our Multiple Sclerosis story and support community on Experience Project. Experience Project is a vast and powerful community where people connect anonymously through life experiences. It's made by the same people who built This is MS, on the premise that no one life experience-- like having MS-- defines a person. It now covers over 2 million life stories. Find and share yours!

Experience Project: I have Multiple Sclerosis

Anonymous Confessions | Free Dream Interpretations | Ask Any Question
Site Map

This site does not offer medical advice. All treatment decisions should always be made with the full consent of your physician.

All logos and trademarks in this site are property of their respective owners. The comments are property of their posters, quoted articles are © referenced source, all the rest © 2002-8 by thisisMS.com.
PHP-Nuke Copyright © 2005 by Francisco Burzi. This is free software, and you may redistribute it under the GPL. PHP-Nuke comes with absolutely no warranty, for details, see the license.
Page Generation: 0.06 Seconds